{"organizations": [], "uuid": "b2e5f6973ab4a0db3e6ecb723fe88c2cf5b38e53", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/02/22/the-associated-press-sangamo-reports-4q-loss.html", "country": "US", "domain_rank": 767, "title": "Sangamo reports 4Q loss", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-22T17:19:00.000+02:00", "replies_count": 0, "uuid": "b2e5f6973ab4a0db3e6ecb723fe88c2cf5b38e53"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/02/22/the-associated-press-sangamo-reports-4q-loss.html", "ord_in_thread": 0, "title": "Sangamo reports 4Q loss", "locations": [], "entities": {"persons": [], "locations": [{"name": "richmond", "sentiment": "none"}, {"name": "calif.", "sentiment": "none"}, {"name": "richmond", "sentiment": "none"}], "organizations": [{"name": "sangamo therapeutics inc.", "sentiment": "negative"}, {"name": "sangamo", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "zacks investment research", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "RICHMOND, Calif. (AP) _ Sangamo Therapeutics Inc. (SGMO) on Thursday reported a loss of $13.1 million in its fourth quarter.\nThe Richmond, California-based company said it had a loss of 15 cents per share.\nThe results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share.\nThe drug developer posted revenue of $13.1 million in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $11.3 million.\nFor the year, the company reported that its loss narrowed to $54.6 million, or 70 cents per share. Revenue was reported as $36.6 million.\nSangamo shares have increased 55 percent since the beginning of the year. The stock has risen sixfold in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on SGMO at https://www.zacks.com/ap/SGMO", "external_links": [], "published": "2018-02-22T17:19:00.000+02:00", "crawled": "2018-02-23T01:05:37.011+02:00", "highlightTitle": ""}